February 12, 2019
Shionogi’s single-dose influenza drug Xofluza (baloxavir marboxil) was the best-selling drug in Japan in January, hauling in sales of 17.4 billion yen on an NHI price basis, according to a monthly snapshot report released by market research firm Encise. Xofluza’s...read more